```markdown
| Cases | Age at diagnosis (years); sex | Histologic diagnosis; tumor location | Prior surgery | Prior therapy | Age on treatment onset (years) | Time on treatment (months) | Best overall response | Functional response | Side effects |
|-------|------------------------------|--------------------------------------|---------------|---------------|--------------------------------|---------------------------|-----------------------|----------------------|--------------|
| Case 1 | 1.5; F                       | PA; medulla oblongata with leptomeningeal dissemination | Biopsy        | CPT 11-CDDP; VBL | 5.8                            | 20                        | PR                    | Stable               | Skin (grade II) Abdominal pain (grade II) CPK and AP increased |
| Case 2 | 0.5; M                       | PMA; hypothalamic-chiasmatic        | Biopsy        | VCR-CBCDA; 5                         | 1                         | 18                        | SD                   | Skin (grade I) Cheilitis (grade I) CPK and ALT increased       |
| Case 3 | 0.9; F                       | PA; intramedullary                  | Biopsy        | VCR-CBCDA; CPT                         | 12                        | 15                        | SD                   | Skin (grade II) Cheilitis (grade II)                            |
| Case 4 | 1; M                         | PMA; hypothalamic-chiasmatic        | Biopsy        | CPT 11-CDDP; VBL; BEV-CDDP; BEV       | 7.5                       | 5                         | SD                   | Improvement of brachial hemiparesis, resolution of paresthesia in hands and torticollis |
| Case 5 | 4.4; F                       | PA; hypothalamic-chiasmatic         | Biopsy        | CPT 11-CDDP; VBL; BEV-CDDP            | 12.5                      | 8                         | PD                   | Visual deterioration                                           |
| Case 6 | 5.8; F                       | PA; intramedullary                  | Biopsy        | CPT 11-CDDP; VBL; BEV-CDDP            | 12.3                      | 15                        | SD                   | Resolution of paresthesia in hands                             |
| Case 7 | 0.8; F                       | PMA; hypothalamic-chiasmatic        | Biopsy        | VCR-CBCDA; BEV                         | 2.8                       | 6                         | PD                   | Increased hemiparesis and cranial nerve abnormalities           |
| Case 8 | 1.8; M                       | PA; hypothalamic-chiasmatic         | Biopsy        | VCR-CBCDA; VBL                         | 2.9                       | 6                         | SD                   | Skin (grade I) Alopecia (grade I) Cheilitis (grade I)          |
| Case 9 | 3.9; M                       | PA; hypothalamic-chiasmatic with leptomeningeal dissemination | Biopsy        | CPT 11-CDDP                             | 9.6                       | 14 (continue)            | SD                   | Skin (grade II) Abdominal pain (grade II) CPK increased (grade II) AST and LDH increased |
| Case 10 | 0.4; M                       | PMA; hypothalamic-chiasmatic        | Biopsy        | VCR-CBCDA; VBL-BEV 1.8                | 10.8                      | 14 (continue)            | SD                   | Skin (grade II) Abdominal pain (grade II) CPK increased (grade II) AST and LDH increased |
| Case 11 | 1.1; F                       | GG; intramedullary                  | Biopsy        | CPT 11-CDDP; VBL; VCR-CBCDA; BEV-CPT 11 | 10.8                      | 12 (continue)            | SD                   | Skin (grade II) Abdominal pain (grade II) CPK increased (grade II) AST and LDH increased |
```

```markdown
Table 1
PLGG with KIAA1549-BRAF fusion: patient characteristics, response, and toxicity with trametinib
```